Rising cases of needle stick injuries, the shift in demand towards ambulatory surgical centers and fusion pumps, and a greater number of surgical procedures performed are poised to benefit the IV equipment market. Furthermore, a prevalence of chronic diseases in an ageing population in developed nations are positive signs for the IV equipment market. However, lack of wireless connectivity, regulatory mandates for new product launches and increasing cases of medication errors inhibit the unencumbered growth of the IV equipment market that is anticipated to witness a steady CAGR of 5% from 2017 to 2022. An ageing population suffering from chronic diseases, particularly in developed regions, is anticipated to demand ever-more surgical procedures. IV therapy is one of the best choices available and this should benefit companies in the IV equipment market. Strong economic growth in Latin America and APEJ are expected to provide significant growth opportunities for companies actively involved in the IV equipment market. Nonetheless, rising prevalence of medication errors, strict regulatory requirements for new equipment and the absence of wireless connectivity in surgical centers and hospitals could stifle the growth in the IV equipment market. The IV catheter segment is the most popular in the IV equipment market and should remain so for the foreseeable future. The IV catheter segment is expected to be worth more than US$ 2.7 billion in 2017 itself and companies are recommended to target this segment with gusto.The securement device segment and stopclocks & valve segment have single digit revenue share in the IV equipment market. While the former is projected to lose market share, the latter is on track to gain share and companies may seek to take advantage of this. The drip chamber and needleless connector segment have a revenue share of less than a tenth in the IV equipment market at the end of 2017. The needleless connector segment is predicted to lose substantial share in the near future while the drip chamber segment should fall slowly. The IV catheter segment accounted for a revenue share approaching one-third of the IV equipment market by product type in 2017 and may gain market share going forward. The IV catheter segment is poised to be worth just under US$ 3.5 billion at the end of the forecast period in 2022, making it large enough for all stakeholders in the IV equipment market. Infusion pumps follow IV catheters in the IV equipment market and have a revenue share of approx. a sixth in terms of product type segment. Europe is the largest region in the infusion pumps market as the continent has a welldeveloped medical infrastructure coupled with a geriatric population that would naturally demand such treatment. Europe is the largest region in the hospital segment of the IV equipment market but there is a close competition for the second place between APEJ and North America. The companies profiled in the IV equipment market are AngioDynamics, Moog Inc., Terumo Corporation, C. R. Bard, ICU Medical, Smiths Group, Baxter International Inc., Fresenius SE & Co., B. Braun Melsungen AG, and Becton, Dickinson and Company. Request sample report @ https://www.persistencemarketresearch.com/samples/19297 About Us Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes. Contact Us Persistence Market Research 305 Broadway 7th Floor, New York City, NY 10007, United States, USA,Canada Toll Free: 800-961-0353 Email: [email protected] Web: http://www.persistencemarketresearch.com

An ageing population suffering from chronic diseases, particularly in developed regions, is anticipated to demand ever-more surgical procedures. IV therapy is one of the best choices available and this should benefit companies in the IV equipment market. Strong economic growth in Latin America and APEJ are expected to provide significant growth opportunities for companies actively involved in the IV equipment market.